Intratumoral B cells as predictive biomarkers for response to immune check point blockade in patients with recurrent ovarian cancer

被引：0
|
作者：
Varghese, Aaron [1 ]
Reddy, Shanmuga [1 ]
Cortes, Eduardo [1 ]
Liu, Song [1 ]
Attwood, Kristopher [1 ]
Odunsi, Kunle [1 ]
Zsiros, Emese [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
361
引用
收藏
页码：S191 / S191
页数：1
相关论文
共 50 条
  • [31] Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S141 - S141
  • [32] Identification of a novel biomarker response in a prospective clinical trial of immune checkpoint blockade in recurrent ovarian carcinoma
    Cun, Han
    Hinchcliff, Emily M.
    Zhu, Ying
    Ferri-Borgogno, Sammy
    Cheng, Rita
    Burks, Jared K.
    Wong, Stephen T.
    Jazaeri, Amir A.
    Mok, Samuel C.
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer
    Benjamin Benzon
    Stephanie A. Glavaris
    Brian W. Simons
    Robert M. Hughes
    Kamyar Ghabili
    Patrick Mullane
    Rebecca Miller
    Katriana Nugent
    Brian Shinder
    Jeffrey Tosoian
    Ephraim J. Fuchs
    Phuoc T. Tran
    Paula J. Hurley
    Milena Vuica-Ross
    Edward M. Schaeffer
    Charles G. Drake
    Ashley E. Ross
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 126 - 136
  • [34] Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer
    Benzon, Benjamin
    Glavaris, Stephanie A.
    Simons, Brian W.
    Hughes, Robert M.
    Ghabili, Kamyar
    Mullane, Patrick
    Miller, Rebecca
    Nugent, Katriana
    Shinder, Brian
    Tosoian, Jeffrey
    Fuchs, Ephraim J.
    Tran, Phuoc T.
    Hurley, Paula J.
    Vuica-Ross, Milena
    Schaeffer, Edward M.
    Drake, Charles G.
    Ross, Ashley E.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (01) : 126 - 136
  • [35] Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
    Luke, Jason John
    Ott, Patrick Alexander
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2457 - 2462
  • [36] PREDICTIVE VALUE OF BIOMARKERS DURING CHEMOTHERAPY IN PATIENTS WITH EPITHELIAL MALIGNANT OVARIAN CANCER
    Parpinel, G.
    Potenza, E.
    Macchi, C.
    Carapezzi, A.
    Laudani, M. E.
    Fuso, L.
    Zola, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A507 - A507
  • [37] PREDICTIVE VALUE OF BIOMARKERS DURING CHEMOTHERAPY IN PATIENTS WITH EPITHELIAL MALIGNANT OVARIAN CANCER
    Zola, P.
    Potenza, E.
    Laudani, M. E.
    Parpinel, G.
    Macchi, C.
    Fuso, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A142 - A142
  • [38] B Cells as an Immune-Regulatory Signature in Ovarian Cancer
    Gupta, Prachi
    Chen, Changliang
    Chaluvally-Raghavan, Pradeep
    Pradeep, Sunila
    CANCERS, 2019, 11 (07)
  • [39] Systemic immune checkpoint blockade and intraperitoneal chemo-immunotherapy in recurrent ovarian cancer: An interim analysis
    Radolec, Mackenzy
    Orr, Brian
    Taylor, Sarah
    Zhang, Lixin
    Mahdi, Haider
    Strange, Mary
    Buckanovich, Ronald
    Edwards, Robert
    Vlad, Anda
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S165 - S166
  • [40] Intratumoral density of regulatory T cells is a predictor of host immune response and chemotherapy response in colorectal cancer
    Oshi, Masanori
    Sarkar, Joy
    Wu, Rongrong
    Tokumaru, Yoshihisa
    Yan, Li
    Nakagawa, Kazuya
    Ishibe, Atsushi
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 490 - 503
12345